The first edition of this book was published in 2003. Over the past 7 years, there have been many advances in the field of hematopoietic SCT, which have been included in the second edition with contributions from experts in their respective fields. Within the section on disease-specific transplants, the 16 chapters dealing with acute myeloid and lymphoid leukemia, chronic myeloid leukemia, lymphoma and multiple myeloma are very balanced and give the reader a true insight into the controversies concerning the appropriate use of myeloablative and reduced-intensity conditioned allograft in each of these disease settings. However, the role of allogeneic stem cell in myeloproliferative disorders is not discussed, other than one paragraph addressing CMML, and myelofibrosis is not mentioned at all; a separate chapter on transplantation in this group of patients would have been a valuable addition to this otherwise excellent book.
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Complications post transplantation, including infections, GVHD and subsequent relapse, and-not to be forgotten-psychological support of the patient and family, are well covered and discussed step by step. The chapters on immune reconstitution, HLA disparity, and the role of T-cell and NK-cell allorecognition in GVHD and GVL are clearly and succinctly presented and provide the reader with a solid background. The sections dedicated to the use of alternative donor source, including HLA-matched unrelated donors and umbilical cord blood, are especially relevant and provide clear recommendations for the clinician. Overall the chapters are remarkably up-to-date; in particular, the sections on haploidentical SCT and umbilical cord blood transplantation provide a very accurate account of the current state-of-the-art.
This book should be regarded as essential reading for anyone involved in making clinical decisions regarding the suitability of a particular patient for transplant, and for those involved in the care of such patients. Given the complexity of the subject, the authors are to be congratulated on producing such a comprehensive guide.
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